Publication Date
In 2025 | 6 |
Since 2024 | 17 |
Since 2021 (last 5 years) | 43 |
Since 2016 (last 10 years) | 86 |
Since 2006 (last 20 years) | 239 |
Descriptor
Adults | 359 |
Drug Therapy | 359 |
Mental Retardation | 98 |
Outcomes of Treatment | 98 |
Symptoms (Individual… | 73 |
Attention Deficit… | 59 |
Children | 55 |
Incidence | 55 |
Foreign Countries | 52 |
Behavior Problems | 50 |
Intervention | 49 |
More ▼ |
Source
Author
Publication Type
Education Level
Higher Education | 9 |
Secondary Education | 8 |
Adult Education | 5 |
Grade 10 | 5 |
Grade 12 | 5 |
Grade 8 | 5 |
High Schools | 5 |
Postsecondary Education | 5 |
Elementary Education | 3 |
Junior High Schools | 3 |
Middle Schools | 3 |
More ▼ |
Audience
Researchers | 17 |
Practitioners | 5 |
Counselors | 3 |
Policymakers | 2 |
Support Staff | 2 |
Teachers | 2 |
Administrators | 1 |
Parents | 1 |
Location
United Kingdom | 14 |
Australia | 6 |
New York | 6 |
Sweden | 5 |
Utah | 5 |
Canada | 4 |
California | 3 |
France | 3 |
Netherlands | 3 |
United Kingdom (London) | 3 |
United States | 3 |
More ▼ |
Laws, Policies, & Programs
Americans with Disabilities… | 1 |
Assessments and Surveys
What Works Clearinghouse Rating
Lenard A. Adler; Deepti Anbarasan; Taylor Sardoff; Terry Leon; Richard Gallagher; Caleb A. Massimi; Stephen V. Faraone – Journal of Attention Disorders, 2024
Objective: To examine the effects of triple beaded mixed amphetamine salts (TB MAS) on ADHD and executive dysfunction symptoms throughout the day in adults with DSM-5 ADHD. Method: This was a 6 week, single-blind, placebo-lead in trial of TB MAS (12.5-37.5 mg/day); all participants received 2 weeks of single-blind placebo); one individual was a…
Descriptors: Adults, Attention Deficit Hyperactivity Disorder, Drug Therapy, Executive Function
Kazunari Yoshida; Yona Lunsky; Daniel J. Müller; Pushpal Desarkar – Journal of Autism and Developmental Disorders, 2025
The aim of this study was to compare the rates of psychotropic medication use and psychotropic polypharmacy between autistic adults with and without intellectual disability (ID) and to examine factors associated with psychotropic medication use and psychotropic polypharmacy in autistic adults, stratified by the presence of ID. We conducted a…
Descriptors: Drug Therapy, Adults, Autism Spectrum Disorders, Intellectual Disability
Jill C. Fodstad; Rachel Russell; Molly Bullington; Lauren B. Jones; Micah Iticovici; Emily Meudt – Journal of Autism and Developmental Disorders, 2025
Purpose: Adolescents and adults with Down syndrome are noted to display symptoms and behaviors consistent with a diagnosis of Obsessive Compulsive Disorder. While evidenced-based interventions, including psychopharmacology and therapeutic interventions including exposure and response prevention, exist and effectively treat obsessive-compulsive…
Descriptors: Adolescents, Adults, Down Syndrome, Anxiety Disorders
Barratt, Macey; Jorgensen, Mikaela; Deb, Shoumitro; Limbu, Bharati; Donley, Mandy; Buchholtz, Moira; Smith, Victoria; Wilson, Nathan – Journal of Applied Research in Intellectual Disabilities, 2023
Background: Adults with intellectual disability are at higher risk of being administered psychotropic medications. The UK-developed SPECTROM (Short-term PsychoEducation for Carers To Reduce Over Medication of people with intellectual disabilities) training programme educates disability support workers on psychotropic medications and alternatives…
Descriptors: Adults, Intellectual Disability, Drug Therapy, Training
Ulrich Elbing; Sebastian Appelbaum; Thomas Ostermann – Journal of Intellectual Disabilities, 2024
This study aims to contribute to the knowledge about lacking or contradictory effects of benzodiazepine on hyperaroused or aggressive behaviour in persons with intellectual disability (ID). We conducted a retrospective and natural case study in a person with mild ID and multiple adverse childhood experiences (ACE), using routine diary data…
Descriptors: Mild Intellectual Disability, Drug Therapy, Behavior Problems, Symptoms (Individual Disorders)
Rudy Arnaud Nana; Serge Clotaire Billong; Jérôme Boombhi; Francky Teddy Endomba; Hilaire Djantio; Alain Menanga – Education and Information Technologies, 2024
Treatment adherence is one of the milestones in the care of hypertensive patients, with new information and communication technologies as potential educational tools. This study aimed to evaluate the add-on effect of a digital cartoon educative video on the therapeutic observance of patients followed up in the General Hospital Yaoundé compared to…
Descriptors: Compliance (Psychology), Hypertension, Patients, Cartoons
Beatriz Manzor-Mitrzyk; Ana I. Lopez-Medina; Karen B. Farris – Health Education Research, 2024
US Latine adults who prefer the Spanish language for healthcare encounter communication have high risk of health disparitiesm in part from low organizational health literacy, mental health stigma and discrimination. Organizational health literacy includes the provision of culturally responsive, language concordant health information, which…
Descriptors: Adults, Hispanic Americans, Language Attitudes, Spanish
Busch, Louis; Saini, Valdeep; Budin, Radek; Jones, Roland M. – Journal of Applied Research in Intellectual Disabilities, 2023
Adults living with intellectual and developmental disabilities are often prescribed psychotropic medication on an "as needed" basis (PRN) in response to behavioural challenges. In the present study we conducted a retrospective analysis of medication administration records in the 6-months preceding and following discharge of 11 adults…
Descriptors: Adults, Patients, Intellectual Disability, Developmental Disabilities
Craig B. H. Surman; Daniel M. Walsh; Joseph B. Bond – Journal of Attention Disorders, 2024
Objective: We appraised whether FDA registration trials for ADHD pharmacotherapy in adults provides comparable information to inform treatment expectations. Method: Comparison of ADHD outcome measure patterns in ADHD pharmacotherapy FDA drug label source studies. Results: Among stimulants, from fixed-dose titration data, amphetamine agents had…
Descriptors: Drug Therapy, Attention Deficit Hyperactivity Disorder, Adults, Stimulants
Anne Halmetoja; Antti Teittinen; Raisa Laaksonen – Journal of Intellectual Disabilities, 2024
Staff in 24/7 group housing services for adults with intellectual disability are responsible for ensuring safe medication management processes and supporting the residents in their health-related issues. Ten interviewed nurses reported several challenges in the medication management process emerging at the staff level, the level of the group home,…
Descriptors: Drug Therapy, Barriers, Group Homes, Intellectual Disability
Benjamin Johnson; Daniel Stjepanovic; Janni Leung; Gary C. K. Chan – Journal of Attention Disorders, 2025
Background: The shortage of prescription stimulants is an ongoing issue that is impacting the ability of individuals with ADHD to access their medication. Amidst concerns that this shortage may have a substantial impact on individuals' ability to manage their symptoms effectively, this research seeks to understand the experiences and consequences…
Descriptors: Attention Deficit Hyperactivity Disorder, Drug Therapy, Stimulants, Access to Health Care
Deb, Shoumitro; Limbu, Bharati; Nancarrow, Tom; Gerrard, David; Shankar, Rohit – Journal of Applied Research in Intellectual Disabilities, 2023
Background: Overprescribing of off-licence psychotropic medications, particularly antipsychotics, for challenging behaviours in people with intellectual disabilities without a psychiatric disorder is a significant public health concern. In the United Kingdom, the National Health Service England launched an initiative in 2016, 'STopping…
Descriptors: Foreign Countries, Psychiatry, Experience, Adults
Laermans, P.; Morisse, F.; Lombardi, M.; Gérard, S.; Vandevelde, S.; de Kuijper, G.; Audenaert, K.; Claes, C. – International Journal of Developmental Disabilities, 2023
Introduction: Adults with intellectual disabilities have an increased vulnerability to mental health problems and challenging behaviour. In addition to psychotherapeutic or psychoeducational methods, off-label pharmacotherapy, is a commonly used treatment modality. Objective: The aim of this study was to establish evidence-based guideline…
Descriptors: Adults, Intellectual Disability, Drug Therapy, Behavior Problems
Beresford, Cathy J.; Kozlowska, Olga – Journal of Applied Research in Intellectual Disabilities, 2022
Background: People with intellectual disabilities are more likely to have diabetes and develop complications from it. Diabetes management is complex and insulin treatment in particular, people with intellectual disabilities may require additional support that is not always available. This review aimed to identify barriers and facilitators to…
Descriptors: Barriers, Affordances, Diabetes, Drug Therapy
Dahlia Leshno; Liat Lev Shalem; Revital Perlov Gavze; Moshe Leshno – Journal of Attention Disorders, 2025
Introduction: Persistence in treatment is important in balancing diabetes and preventing complications. ADHD impairs quality of life and functioning in many areas of life. The aim of this study is to evaluate the possible association of ADHD and diabetes glycemic control among adults with type 2 diabetes mellitus (T2DM). Methods: All data were…
Descriptors: Diabetes, Patients, Biochemistry, Prevention